Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

Background Long-term aspirin prevents vascular events but is only modestly effective. Rivaroxaban alone or in combination with aspirin might be more effective than aspirin alone for vascular prevention in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD). Rivaroxa...

全面介紹

書目詳細資料
發表在:	Canadian Journal of Cardiology
主要作者:	2-s2.0-85026258046
格式:	Article
語言:	English
出版:	Pulsus Group Inc. 2017
在線閱讀:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026258046&doi=10.1016%2fj.cjca.2017.06.001&partnerID=40&md5=23d00519f29c96c7468bdcfef2dd3b67

因特網

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026258046&doi=10.1016%2fj.cjca.2017.06.001&partnerID=40&md5=23d00519f29c96c7468bdcfef2dd3b67

相似書籍

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial
由: Bosch J.; Eikelboom J.W.; Connolly S.J.; Bruns N.C.; Lanius V.; Yuan F.; Misselwitz F.; Chen E.; Diaz R.; Alings M.; Lonn E.M.; Widimsky P.; Hori M.; Avezum A.; Piegas L.S.; Bhatt D.L.; Branch K.R.H.; Probstfield J.L.; Liang Y.; Liu L.; Zhu J.; Maggioni A.P.; Lopez-Jaramillo P.; O'Donnell M.; Fox K.A.A.; Kakkar A.; Parkhomenko A.N.; Ertl G.; Störk S.; Keltai K.; Keltai M.; Ryden L.; Dagenais G.R.; Pogosova N.; Dans A.L.; Lanas F.; Commerford P.J.; Torp-Pedersen C.; Guzik T.J.; Verhamme P.B.; Vinereanu D.; Kim J.-H.; Ha J.-W.; Tonkin A.M.; Varigos J.D.; Lewis B.S.; Felix C.; Yusoff K.; Steg P.G.; Aboyans V.; Metsarinne K.P.; Anand S.S.; Hart R.G.; Lamy A.; Moayyedi P.; Leong D.P.; Sharma M.; Yusuf S.
出版: (2017)
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics
由: Lonn E.; Bosch J.; Pogue J.; Avezum A.; Chazova I.; Dans A.; Diaz R.; Fodor G.J.; Held C.; Jansky P.; Keltai M.; Keltai K.; Kunti K.; Kim J.-H.; Leiter L.; Lewis B.; Liu L.; Lopez-Jaramillo P.; Pais P.; Parkhomenko A.; Peters R.J.G.; Piegas L.S.; Reid C.M.; Sliwa K.; Toff W.D.; Varigos J.; Xavier D.; Yusoff K.; Zhu J.; Dagenais G.; Yusuf S.
出版: (2016)
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study
由: Schwalm J.-D.R.; McCready T.; Lamelas P.; Musa H.; Lopez-Jaramillo P.; Yusoff K.; McKee M.; Camacho P.A.; Lopez-Lopez J.; Majid F.; Thabane L.; Islam S.; Yusuf S.
出版: (2018)
Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study
由: 2-s2.0-85049739079
出版: (2018)
Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent
由: Kamal F.; Othman H.R.
出版: (2025)